Is tumor (R)ejection by the immune system the "5th R" of radiobiology?

OncoImmunology

Volumn 3, Issue 3, 2014, Pages

  Golden, Encouse B ^a   Formenti, Silvia C ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Abscopal effect; ATP; Calreticulin; CTLA4; CXCL16; CXCR6; HMGB1; Immunogenic cell death; Ionizing irradiation; Ipilimumab; NKG2D; Radiobiology; RAE 1

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; DNA; IPILIMUMAB;

ADAPTIVE IMMUNITY; ARTICLE; CANCER IMMUNOTHERAPY; CANCER RADIOTHERAPY; CELL KILLING; CYTOKINE RELEASE; DNA DAMAGE; DNA REPAIR; GENETIC REASSORTMENT; HUMAN; IMMUNE SYSTEM; IMMUNOGENICITY; INNATE IMMUNITY; IONIZING RADIATION; LUNG CANCER; NONHUMAN; RADIOBIOLOGY; REOXYGENATION; SIGNAL TRANSDUCTION; TREATMENT RESPONSE; TUMOR CELL; TUMOR MICROENVIRONMENT; TUMOR REJECTION;

EID: 84902480054     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.4161/onci.28133     Document Type: Article

References (11)

1. Ma Y, Kepp O, Ghiringhelli F, Apetoh L, Aymeric L, Locher C, Tesniere A, Martins I, Ly A, Haynes NM, et al. Chemotherapy and radiotherapy: cryptic anticancer vaccines. Semin Immunol 2010; 22: 113-24. PMID:20403709; http://dx.doi.org/10.1016/j. smim.2010.03.001
2. Golden E, Francis D, Pellicciotta I, Demaria S, Helen Barcellos-Hoff M, Formenti S. Radiation fosters dose-dependent and chemotherapy-induced immunogenic cell death. OncoImmunology 2014; 3:(Forthcoming) http://dx.doi.org/10.4161/onci.28518
3. Formenti SC, Demaria S. Combining radiotherapy and cancer immunotherapy: a paradigm shift. J Natl Cancer Inst 2013; 105: 256-65. PMID:23291374; http://dx.doi.org/10.1093/jnci/djs629
4. Klug F, Prakash H, Huber PE, Seibel T, Bender N, Halama N, Pfirschke C, Voss RH, Timke C, Umansky L, et al. Low-dose irradiation programs macrophage differentiation to an iNOS+/M1 phenotype that orchestrates effective T cell immunotherapy. Cancer Cell 2013; 24: 589-602. PMID:24209604; http://dx.doi.org/10.1016/j.ccr.2013.09.014
5. Demaria S, Kawashima N, Yang AM, Devitt ML, Babb JS, Allison JP, Formenti SC. Immune-mediated inhibition of metastases after treatment with local radiation and CTLA-4 blockade in a mouse model of breast cancer. Clin Cancer Res 2005; 11:728-34; PMID:15701862
6. Postow MA, Callahan MK, Barker CA, Yamada Y, Yuan J, Kitano S, Mu Z, Rasalan T, Adamow M, Ritter E, et al. Immunologic correlates of the abscopal effect in a patient with melanoma. N Engl J Med 2012; 366: 925-31. PMID:22397654; http://dx.doi. org/10.1056/NEJMoa1112824
7. Stamell EF, Wolchok JD, Gnjatic S, Lee NY, Brownell I. The abscopal effect associated with a systemic antimelanoma immune response. Int J Radiat Oncol Biol Phys 2013; 85: 293-5. PMID:22560555; http://dx.doi.org/10.1016/j.ijrobp.2012.03.017
8. Golden EB, Demaria S, Schiff PB, Chachoua A, Formenti SC. An Abscopal Response to Radiation and Ipilimumab in a Patient with Metastatic Non-Small Cell Lung Cancer. Cancer Immunol Res 2013; 1: 365-72. PMID:24563870; http://dx.doi. org/10.1158/2326-6066.CIR-13-0115
9. Kitano S, et al. Myeloid-derived suppressor cell quantity prior to treatment with ipilimumab at 10 mg/kg to predict for overall survival in patients with metastatic melanoma. J Clin Oncol 2012; 30: suppl; abstr 2518
10. Ruocco MG, Pilones KA, Kawashima N, Cammer M, Huang J, Babb JS, Liu M, Formenti SC, Dustin ML, Demaria S. Suppressing T cell motility induced by anti-CTLA-4 monotherapy improves antitumor effects. J Clin Invest 2012; 122: 3718-30. PMID:22945631; http://dx.doi.org/10.1172/JCI61931
11. Fowler JF. 21 years of biologically effective dose. Br J Radiol 2010; 83: 554-68. PMID:20603408; http://dx.doi.org/10.1259/bjr/31372149